Article Text
Therapeutics
Systematic review
Tricyclic antidepressants reduce frequency of tension-type and migraine headaches compared with placebo, and intensity of headaches compared with SSRIs, but cause greater adverse effects
Statistics from Altmetric.com
Footnotes
-
Competing interests PDM has received support from Merck Serono, Novartis and Bayer Schering to attend conferences.